Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:10:18 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



News for U:LYRA from 2023-05-18 to 2024-05-17 - 17 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-06 07:59U:LYRANews ReleaseLyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
2024-04-30 16:04U:LYRANews ReleaseLyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
2024-04-26 16:51U:LYRANews ReleaseLyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-21 16:01U:LYRANews ReleaseLyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2024-03-01 16:01U:LYRANews ReleaseLyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-11-07 16:01U:LYRANews ReleaseLyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-11-07 07:00U:LYRANews ReleaseLyra Therapeutics to Participate in Upcoming Investor Conferences
2023-10-16 07:00U:LYRANews ReleaseLyra Therapeutics Announces Appointment of Ronan O ¢ € ™Brien as Chief Legal Officer
2023-09-12 07:00U:LYRANews ReleaseLyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgery
2023-09-06 08:00U:LYRANews ReleaseLyra Therapeutics to Participate in Upcoming Investor Conferences
2023-08-29 07:00U:LYRANews ReleaseLyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis
2023-08-08 16:01U:LYRANews ReleaseLyra Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2023-07-13 07:30U:LYRANews ReleaseLyra Therapeutics to Present at William Blair Virtual Biotechnology Conference
2023-06-02 16:01U:LYRANews ReleaseLyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-06-02 07:30U:LYRANews ReleaseLyra Therapeutics to Present at Jefferies Healthcare Conference
2023-06-01 07:29U:LYRANews ReleaseLyra Therapeutics Announces Closing of $50.0 Million Private Placement
2023-05-26 07:58U:LYRANews ReleaseLyra Therapeutics Announces $50.0 Million Private Placement